Skip to main content
Clinical Trials/NCT05900518
NCT05900518
Completed
Not Applicable

A Promising Minimally Invasive Surgical Technique for the Treatment of Infected Pilonidal Sinus

Fondation Hôpital Saint-Joseph1 site in 1 country113 target enrollmentJune 27, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infected Pilonidal Sinus
Sponsor
Fondation Hôpital Saint-Joseph
Enrollment
113
Locations
1
Primary Endpoint
Clinical cure
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Infected pilonidal sinuses are a common pathology, affecting an estimated 0.7% of the population. In France, the most commun technique is extended exeresis with an open wound, followed by directed healing. This technique reduces the risk of recurrence, albeit at the cost of daily nursing care and a long healing period involving prolonged absence from work. Closure or plasty surgical techniques aimed at reducing the duration of nursing care are more restrictive, and seem to have higher recurrence rate. Minimally invasive treatment, such as phenolization and flattening with curettage of the sinus have existed for over 50 years, albeit with disappointing long-term results and morbidity that limits their application.

Today, new minimally invasive treatments are being developed, aiming at a less constraining post-operative period. without compromising healing. These include glue, endoscopic treatment (EPSiT : Endoscopic Pilonidal Sinus Treatment or VAASP : Video-Assisted Ablation of Pilonidal Sinus) and laser treatment (SiLaT procedure : Sinus Laser Therapy or PiLaT : Pilonidal disease Laser Treatment).

Laser treatment is used since 2014 in the treatment of anal fistulas and more recently in the treatment of infected pilonidal sinus. A laser fiber is introduced, under local or general anaesthesia, into the main cavity and secondary tracts after curettage and opening of the dimples. The energy delivered by the laser is transmitted in the form of heat, in order to seal the cavity during healing of thermal lesions.

Initial results report success rates of around 90%, with a healing time of between 1 and 2 months. It also appears to be effective after failure of previous surgery. In cases of incomplete closure or recurrence, a second laser treatment can be performed with high healing rates. The investigators carried out an retrospective study including 29 patients treated with the SILAT technique. The healing rate, defined as the absence of symptoms and recurrence of suppuration, was around 70%. The procedure was painless and no serious complications were observed. The presence of one or more secondary orifices and overweight were associated with a higher risk of failure.

In order to confirm these results, to better specify the factors predictive of success, and to evaluate the efficacy of SiLaT in the longer term, the investigators will carry out a single-center study including all adult patients treated with laser between June 2018 and December 2020.

Registry
clinicaltrials.gov
Start Date
June 27, 2018
End Date
October 14, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient aged 18 or above
  • French-speaking patient
  • Patient hospitalized in the Proctology department of GHPSJ between 01JUN2018 and 31DEC2020 for a chronically infected pilonidal sinus
  • patient presenting an recurring infected pilonidal sinus after open or closed surgical treatment

Exclusion Criteria

  • Patient hospitalized in the acute abcess stage of an infected pilonidal sinus
  • Patient under guardianship or curatorship
  • Patient incarcerated
  • Patient under legal protection
  • Patient refusing enrollment

Outcomes

Primary Outcomes

Clinical cure

Time Frame: between 6 months and 36 months after treatment

A clinical evaluation will be performed and Clinical cure will be defined by : closure of all existing fistula external opening AND absence of abscess, AND absence of leakage under pressure, and ABSENCE of pain

Secondary Outcomes

  • recurrence Rate(between 6 months and 36 months after treatment)
  • Incidence rate of complication after laser treatment(between 6 months and 36 months after treatment)
  • description of predictive failure factors(between 6 months and 36 months after treatment)

Study Sites (1)

Loading locations...

Similar Trials